Award Information: Funding up to two years with total direct costs up to $275,000; no preliminary data is required but may be included if available; budgets in modular format
Description: The R21 mechanism is intended to encourage new, exploratory and developmental research projects by providing support for the early stages of their development. All investigator-initiated exploratory/developmental grant applications described in this announcement will be assigned to ICs according to standard PHS referral guidelines and specific program interests. Applications that are assigned to non-participating ICs may be returned to the applicant. Such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models or applications that could have major impact on a field of biomedical, behavioral, or clinical research.